Explaining Type 2 Diabetes with Transcriptomic Signatures of Pancreatic β-Cell Dysfunction and Death Induced by Human...

Area of Science:

• Molecular biology
• Genomics
• Endocrinology

Background:

• Amyloid deposits from human islet amyloid polypeptide (hIAPP) misfolding are implicated in type 2 diabetes mellitus (T2DM).
• The precise molecular mechanisms of hIAPP-induced pancreatic beta-cell cytotoxicity remain unclear.
• Understanding these mechanisms is crucial for developing effective T2DM treatments.

Purpose of the Study:

• To investigate the molecular pathways underlying hIAPP-induced cytotoxicity in pancreatic beta-cells.
• To identify key genes and pathways affected by hIAPP overexpression using bioinformatics analysis of public datasets.
• To explore potential therapeutic targets for T2DM based on identified molecular players.

Main Methods:

• Combined analysis of Affymetrix microarray and high-throughput sequencing Gene Expression Omnibus (GEO) datasets from hIAPP-transgenic and wild-type mice islets.
• Weighted gene coexpression network analysis (WGCNA) to identify gene modules correlated with hIAPP overexpression.
• Differential gene expression analysis and network analysis (using Cytoscape) to identify hub genes and associated pathways.

Main Results:

• Seven hub genes (Ins2, Agt, Jun, Fos, CD44, Igf1, Ppar-γ) were identified.
• These genes are significantly involved in insulin synthesis/secretion, insulin resistance, oxidative stress, inflammation, mitophagy, and apoptosis.
• Network analysis revealed distinct pathways associated with hIAPP overexpression.

Conclusions:

• The identified hub genes provide insights into the pathogenesis of T2DM driven by hIAPP.
• These genes represent potential therapeutic targets for clinical management of T2DM.
• Further research into these targets could lead to novel interventions for hIAPP-related diabetes.